Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils.
Ontology highlight
ABSTRACT: Devil facial tumour disease (DFTD) is a transmissible cancer devastating the Tasmanian devil (Sarcophilus harrisii) population. The cancer cell is the 'infectious' agent transmitted as an allograft by biting. Animals usually die within a few months with no evidence of antibody or immune cell responses against the DFTD allograft. This lack of anti-tumour immunity is attributed to an absence of cell surface major histocompatibility complex (MHC)-I molecule expression. While the endangerment of the devil population precludes experimentation on large experimental groups, those examined in our study indicated that immunisation and immunotherapy with DFTD cells expressing surface MHC-I corresponded with effective anti-tumour responses. Tumour engraftment did not occur in one of the five immunise
SUBMITTER: Tovar C
PROVIDER: S-EPMC5343465 | biostudies-literature | 2017 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA